Who’s Using GLP-1 Medications? Study Finds Major Shift in Patient Population
A new study finds GLP-1 medications like Ozempic and Wegovy are now being prescribed more often for obesity than type 2 diabetes.
Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.